PCN302 - IS THE NEW NICE APPRAISAL PROCESS FOR ONCOLOGY INDICATIONS TOO POSITIVE IN ITS ASSESSMENT OF CANCER DRUGS IN ENGLAND?

Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.384
https://www.valueinhealthjournal.com/article/S1098-3015(18)33684-2/fulltext
Section Title :
Section Order : 2286
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33684-2&doi=10.1016/j.jval.2018.09.384
HEOR Topics :
Tags :
Regions :